Raul Delapena Setiawan

Bausch + Lomb Advances Two Ophthalmic Candidates to Next Clinical Stages Amidst Promising, Yet Nuanced, Trial Results

• Medical Research and Clinical Trials

Bausch + Lomb Advances Two Ophthalmic Candidates to Next Clinical Stages Amidst Promising, Yet Nuanced, Trial Results

Raul Delapena Setiawan August 27, 2026

ROCHESTER, NY – [Insert Date] – Bausch + Lomb, a global leader in eye health, has announced...

Read More Read more about Bausch + Lomb Advances Two Ophthalmic Candidates to Next Clinical Stages Amidst Promising, Yet Nuanced, Trial Results

Public Health at a Crossroads: White House Executive Order Challenges Decades of Vaccine Policy Amid Measles Surge

• Treatment Innovations

Public Health at a Crossroads: White House Executive Order Challenges Decades of Vaccine Policy Amid Measles Surge

Raul Delapena Setiawan August 26, 2026

As the United States grapples with its most significant measles resurgence in 35 years, the federal government...

Read More Read more about Public Health at a Crossroads: White House Executive Order Challenges Decades of Vaccine Policy Amid Measles Surge

The Final Chapter: Navigating the 2026 Pisces Lunar Eclipse

• Integrative Oncology and Holistic Care

The Final Chapter: Navigating the 2026 Pisces Lunar Eclipse

Raul Delapena Setiawan August 26, 2026

Published: August 26, 2026 | 05:05 AM As the cosmic clock strikes a pivotal hour, the sky...

Read More Read more about The Final Chapter: Navigating the 2026 Pisces Lunar Eclipse

Empowering Action: A Comprehensive Guide to Planning an Impactful Breast Cancer Awareness Month

• Patient Advocacy and Support

Empowering Action: A Comprehensive Guide to Planning an Impactful Breast Cancer Awareness Month

Raul Delapena Setiawan August 26, 2026

Breast Cancer Awareness Month (BCAM), observed annually in October, serves as a crucial period for collective action,...

Read More Read more about Empowering Action: A Comprehensive Guide to Planning an Impactful Breast Cancer Awareness Month

Ziihera’s Expanded FDA Approval: A New Era for Jazz Pharmaceuticals and Oncology Care

• Treatment Innovations

Ziihera’s Expanded FDA Approval: A New Era for Jazz Pharmaceuticals and Oncology Care

Raul Delapena Setiawan August 26, 2026

By Jonathan Gardner | Published August 25, 2026 In a significant regulatory victory that promises to reshape...

Read More Read more about Ziihera’s Expanded FDA Approval: A New Era for Jazz Pharmaceuticals and Oncology Care

Removing ovaries and fallopian tubes linked to lower risk of early death among breast cancer patients with BRCA cancer genes

• Medical Research and Clinical Trials

Removing ovaries and fallopian tubes linked to lower risk of early death among breast cancer patients with BRCA cancer genes

Raul Delapena Setiawan August 25, 2026

Cambridge, UK – [Insert Current Date] – A groundbreaking study from the University of Cambridge, published today...

Read More Read more about Removing ovaries and fallopian tubes linked to lower risk of early death among breast cancer patients with BRCA cancer genes

Liminatus Pharma Taps Synex Consulting for Crucial Phase I/IIa Trial of Innovative CAR-T Therapy IBC101 in South Korea

• Medical Research and Clinical Trials

Liminatus Pharma Taps Synex Consulting for Crucial Phase I/IIa Trial of Innovative CAR-T Therapy IBC101 in South Korea

Raul Delapena Setiawan August 25, 2026

Seoul, South Korea – [Insert Date] – Liminatus Pharma, a biopharmaceutical company focused on developing novel therapies...

Read More Read more about Liminatus Pharma Taps Synex Consulting for Crucial Phase I/IIa Trial of Innovative CAR-T Therapy IBC101 in South Korea

Roche Enters the Next Frontier of Obesity Care with $2.3 Billion Hanmi Pharma Deal

• Chemotherapy and Targeted Therapy

Roche Enters the Next Frontier of Obesity Care with $2.3 Billion Hanmi Pharma Deal

Raul Delapena Setiawan August 25, 2026

By Jonathan Gardner Published August 24, 2026 In a strategic maneuver that underscores the shifting tides of...

Read More Read more about Roche Enters the Next Frontier of Obesity Care with $2.3 Billion Hanmi Pharma Deal

Advancing the Frontlines: A President’s Dispatch on the Future of Metastatic Breast Cancer Research

• Metastatic Breast Cancer Research

Advancing the Frontlines: A President’s Dispatch on the Future of Metastatic Breast Cancer Research

Raul Delapena Setiawan August 24, 2026

Executive Summary: The State of the Foundation As the landscape of medical research continues to evolve at...

Read More Read more about Advancing the Frontlines: A President’s Dispatch on the Future of Metastatic Breast Cancer Research

Protecting the Vulnerable: METAvivor Urges FDA to Restore Universal Vaccine Access Ahead of 2026–2027 COVID-19 Season

• Patient Advocacy and Support

Protecting the Vulnerable: METAvivor Urges FDA to Restore Universal Vaccine Access Ahead of 2026–2027 COVID-19 Season

Raul Delapena Setiawan August 24, 2026

ANNAPOLIS, MD — As the federal government prepares to finalize the public health strategy for the upcoming...

Read More Read more about Protecting the Vulnerable: METAvivor Urges FDA to Restore Universal Vaccine Access Ahead of 2026–2027 COVID-19 Season